Harbin Gloria Pharmaceuticals
2
55M
2
0.10
2
- Areas of investment
Summary
Harbin Gloria Pharmaceuticals is the famous Corporate Investor, which was founded in 2000. The company was established in Asia in China. The main office of represented Corporate Investor is situated in the Harbin.
The common things for fund are deals in the range of more than 100 millions dollars. The high activity for fund was in 2016. The fund is constantly included in less than 2 investment rounds annually.
Among the most popular fund investment industries, there are Health Care, Mobile. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 11-15 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Proteus Digital Health
The standard case for the fund is to invest in rounds with 1 partaker. Despite the Harbin Gloria Pharmaceuticals, startups are often financed by Yuan Capital, Silicon Valley Bank, Sailing Capital.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 2
- Rounds per year
- 0.10
- Investments by industry
- Health Care (1)
- Mobile (1)
- Medical (1)
- Pharmaceutical (1)
- Asset Management (1) Show 2 more
- Investments by region
-
- United States (1)
- China (1)
- Peak activity year
- 2016
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 14
- Avg. valuation at time of investment
- 500M
- Strategy success index
- 0.57
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| JYC99.com | 02 Dec 2016 | Asset Management, Financial Services, Service Industry | Early Stage Venture | 1M | Zhejiang, Shangcheng District, China |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.